Epicardial adipose tissue thickness is an indicator for coronary artery stenosis in asymptomatic type 2 diabetic patients: its assessment by cardiac magnetic resonance

Table 4 A comparison of silent myocardial ischemia based on CMR findings

	Silent myocardial ischemia (n = 14)	No silent myocardial ischemia (n = 86)	*p value*
Age (years)	58 ± 8	56 ± 7	0.278
Body-mass index (kg/m²)	27.3 ± 3.8	25.0 ± 3.0	0.033*
Waist-to-hip ratio	0.94 ± 0.06	0.90 ± 0.05	0.087
Systolic blood pressure (mmHg)	133 ± 9	130 ± 13	0.358
Diastolic blood pressure (mmHg)	74 ± 6	77 ± 10	0.305
DM duration (years)	10.1 ± 7.5	8.1 ± 6.5	0.396
Smoking history (n, %)	2 (14.3)	16 (19.0)	0.503
Fasting glucose (mmol/L)	6.3 ± 2.0	6.8 ± 1.6	0.072
Postprandial glucose (mmol/L)	13.4 ± 3.6	12.3 ± 3.9	0.200
HbA1c (%)	7.2 ± 0.8	7.0 ± 0.9	0.236
GA (%)	17.9 ± 3.9	16.5 ± 3.9	0.203
Total cholesterol (mmol/L)	4.4 ± 0.9	4.3 ± 0.8	0.941
LDL cholesterol (mmol/L)	2.7 ± 1.3	2.4 ± 0.7	0.602
HDL cholesterol (mmol/L)	1.2 ± 0.2	1.1 ± 0.2	0.453
Triglyceride (mmol/L)	1.3 ± 0.5	1.5 ± 0.7	0.295
HOMA-IR	4.4 ± 3.5	5.0 ± 8.2	0.649
Cardiovascular magnetic resonance
EAT thickness (mm)	12.8 ± 2.1	11.7 ± 2.3	0.111
LV ejection fraction (%)	69 ± 5	68 ± 3	0.353
LV mass (g)	87 ± 28	82 ± 19	0.739

Data are presented as mean ± s.d. or n(%). DM diabetes mellitus; HbA1c glycated hemoglobin; GA glycated albumin; LDL low-density lipoprotein; HDL high-density lipoprotein; HOMA-IR homeostasis model assess of insulin resistance; EAT epicardial adipose tissue; LV left ventricle.
* p<0.05, **p<0.01, ***p<0.001.

ISSN: 1475-2840